CONMED Corporation (CNMD)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $1.51B
Last updated: Nov 17, 2026 at 11:04 AM ET
CONMED Corporation (CNMD) Stock Forecast
Analysts expect CONMED (CNMD) to earn $4.57 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.36B. Of 7 analysts, 0 rate the stock Buy or Strong Buy, 6 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 6 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 3.29, inside the Hold band from 2.5 up to 3.5. Sell and Strong Sell make up 14% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 6 | 85.7% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 14.3% |
- Consensus
- Hold
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 3.9% and revenue estimates rise 5.1%.
- Fiscal year ending Dec 31, 2026
- $4.57
- EPS consensus, revenue $1.36B
- Fiscal year ending Dec 31, 2027
- $4.75
- EPS consensus, revenue $1.43B
- Next report
- Jan 26, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.57 | $4.56 to $4.58 | 7 | $1.36B | $1.36B to $1.36B | 7 |
| Dec 31, 2027 | $4.75 | $4.63 to $4.91 | 7 | $1.43B | $1.41B to $1.43B | 7 |
Quarterly Estimates
The EPS consensus falls from $1.29 for the quarter ending Dec 31, 2026 to $0.98 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.29 | $1.23 to $1.33 | 9 | $373.88M | $357.99M to $385.35M | 9 |
| Mar 31, 2027 | $0.98 | $0.90 to $1.10 | 5 | $329.30M | $325.49M to $333.12M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 14 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 6 | 0 |
| Fiscal year ending Dec 31, 2027 | 4 | 1 |
| Quarter ending Mar 31, 2027 | 4 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.7% from $4.54.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.57 | $4.54 | $4.54 | $4.54 | $4.54 | +0.8% |
| Fiscal year ending Dec 31, 2027 | $4.75 | $4.78 | $4.78 | $4.78 | $4.78 | -0.7% |
| Quarter ending Mar 31, 2027 | $0.98 | $0.97 | $0.97 | $0.97 | $0.97 | +0.8% |
Frequently Asked Questions About CNMD
What is the CNMD stock forecast?
Consensus analyst estimates put CONMED's EPS at $4.57 for the fiscal year ending Dec 31, 2026, on revenue of $1.36B. The consensus rating from 7 analysts is Hold.
How do analysts rate CNMD stock?
Of 7 analysts covering CONMED, 0 rate it Strong Buy, 0 Buy, 6 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from CNMD next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.57, with estimates from $4.56 to $4.58 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.75, with estimates from $4.63 to $4.91 from 7 analysts.
What revenue do analysts expect from CONMED next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.36B, with estimates from $1.36B to $1.36B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.43B, with estimates from $1.41B to $1.43B.
How many analysts cover CNMD?
7 analysts rate CONMED stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CNMD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts